More than 1.8 million boxes of eye drops have been ripped off shelves across the U.S. after shocking FDA revelations exposed major sterility failures at the heart of their production.
AvKARE, one of the biggest pharmaceutical names in the country, is in the hot seat — and it’s getting hotter by the minute.
That’s not an exaggeration. That’s straight from the FDA, which issued a Class II recall — the kind that screams: “Serious health risk ahead!”
“I trusted these drops. Now my eyes are red, irritated, and I’m scared,” said one terrified customer who spoke with Health.com.
So what’s the deal?
According to reports, AvKARE’s products were manufactured under dirty, dangerous, and completely unacceptable conditions. We’re talking about prescription-grade eye solutions — the stuff doctors hand out. The recall includes:
- Artificial Tears
- Carboxymethylcellulose Sodium Ophthalmic Gel 1%
- Polyvinyl Alcohol Ophthalmic Solution
- And others you probably have in your bathroom right now
Social media is already erupting. TikTok users are uploading “eye drop hauls” only to cut to bandaged eyes and furious rants. The hashtag #EyedropRecall is going viral — and for good reason.
It’s a full-on public health scare. People rely on these products for comfort, for clarity, for their basic ability to function — and now they’re being told they could’ve gone blind?
As first reported by CTInsider, the recall affects products distributed between May 2023 and April 2025. That’s nearly two years’ worth of contaminated eye care flooding into homes, hospitals, and pharmacies.
Many of these eye drops are still out there. Sitting in medicine cabinets right now. If you’re reading this, go check your shelf.
The FDA advises users to stop using the products immediately and contact AvKARE for return instructions. But is that really enough? Lawsuits could be looming. Outrage is already exploding.
In the past year, brands like EzriCare, Systane, and now AvKARE have faced similar scrutiny. Are we facing a systemic failure in eye care safety?
Insiders claim that poor oversight and rushed production to meet demand are at the root of the problem. And with more people working on screens all day, demand for eye care products is at an all-time high.
Leave a Reply